SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-18-003764
Filing Date
2018-05-15
Accepted
2018-05-15 15:58:21
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 anth51018010q.htm 10-Q 751191
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 14944
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 14535
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5306
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5284
  Complete submission text file 0001214659-18-003764.txt   3403964

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anth-20180331.xml EX-101.INS 535361
7 XBRL TAXONOMY EXTENSION SCHEMA anth-20180331.xsd EX-101.SCH 38119
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anth-20180331_cal.xml EX-101.CAL 37676
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anth-20180331_def.xml EX-101.DEF 172448
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anth-20180331_lab.xml EX-101.LAB 293751
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anth-20180331_pre.xml EX-101.PRE 232411
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 18836097
SIC: 2834 Pharmaceutical Preparations